Get startedLog in
    Picture of Sumitomo Pharma logo

    4506 — Sumitomo Pharma News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapValue Trap
    All News

    Brief: Sumitomo Pharma Announces Authorization In Canada Of Orgovyx (Relugolix) For The Treatment Of Men With Advanced Prostate Cancer

    Picture of Sumitomo Pharma logoSumitomo Pharma
    23/10/2023 14:00
    Oct 23 (Reuters) - Sumitomo Pharma Co Ltd  4506.T :
    * SUMITOMO PHARMA ANNOUNCES AUTHORIZATION IN CANADA OF
ORGOVYX
(RELUGOLIX) FOR THE TREATMENT OF MEN WITH ADVANCED PROSTATE
CANCER

Source text for Eikon:  ID:nPn5M63Qca 
Further company coverage:  4506.T 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Sumitomo Pharma

    See all news